Country for PR: United Kingdom
Contributor: PR Newswire Europe
Tuesday, May 24 2022 - 09:00
OptraSCAN's Artificial Intelligence-Equipped Digital Pathology Scanner OS-SiA Granted U.S Patent for Scanning, Indexing and Analyzing of the Tissue Area at the Same Time
SAN JOSE, Calif., May 24, 2022 /PRNewswire-AsiaNet/ --

    OptraSCAN(R) [], the leading end-to-end digital 
pathology solution provider, announced its digital pathology scanner OS-SiA has 
been granted US patent - No 2020/0334814 A1 by the United States Patent and 
Trademark Office. OS-SiA has inbuilt intelligence to scan, index and analyze 
pathological samples simultaneously. This will benefit the end-user to view the 
whole slide scanned image along with analyzed output as an overlay during their 
review process.

    The patent describes a technique invented by OptraSCAN, the AI-enabled 
digital pathology scanner OS-SiA 
[] automatically 
identifies specimens to scan and simultaneously analyzes the tissue or cell 
area being scanned. OS-SiA is the industry's first AI-enabled digital scanner 
that will provide real-time predictive analysis and actionable insights.

    "Currently, the digital pathology slide scanners are restricted to partial 
or whole slide image acquisition and digitization into an image. Our 
next-generation scanner OS-SiA scans and analyzes simultaneously eliminating 
the need for additional processing applications," said Abhi Gholap, Founder & 
CEO, OptraSCAN. "This patent highlights our constant efforts to improve the 
adoption of digital pathology solutions and support the pathology community."
    OS-SiA can be embedded in the existing series of its cloud-enabled 
brightfield scanners namely OS-Lite & OS-Ultra. The custom algorithms provide 
real-time ROI detection while scanning, cell quantification for IHC/HNE 
markers, and morphological measurements built using the core library. The whole 
slide image can be viewed in a local / web-based / cloud-based image viewer. 
The deep learning computational module is provided for self-learning in the 
scanning device.

    "This is the kind of breakthrough we need to accelerate the adoption of 
digital pathology, simultaneous scanning and analysis will help pathologists 
make faster decisions and improve patient outcomes." Dr. Zu-Hua Gao MD, Medic

    About OptraSCAN, Inc:

    OptraSCAN(R) [] are pioneers in the On-Demand 
Digital Pathology(R) System, focused on delivering fully integrated, affordable 
solutions that will maximize your return on investment and improve the 
performance of your pathology services. An ISO 13485 certified company and CE 
marked whole slide scanners for IVD use, OptraSCAN is working to eliminate the 
barriers to 'Go Digital' no matter the size of the pathology lab, the lab's 
throughput, or global location.

    OptraSCAN's end-to-end digital pathology solution provides effective 
acquisition of whole slide images, viewing, storing, real-time sharing, 
reporting and AI & ML based Image analysis solutions via On-Demand or outright 
purchase model. Follow Us on LinkedIn 
[] and Twitter 


    Source: OptraSCAN Inc.